<i>BRCA</i> mutation frequency and clinical features of ovarian cancer patients: A report from a Chinese study group

Abstract

BRCA1/2 mutation prevalence in Chinese ovarian cancer patients is higher than the international rate. We recommend BRCA1/2 testing for patients with family histories and personal histories of malignancy and genetic counseling for cancer in healthy people with high-risk family histories.